Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

31/12/20181.76
Expand
titleGET /loans/accounting-transaction-related-accounting-ratios (153-WM_LN-A_Mortgage)

The following table shows for a

  • specific tenant (companyId) and for
  • deal (dealId) "153-WM_LN-A_Mortgage" and for 
  • GAAP (gaap) "IFRS"

accounting transactions at various posting dates (postingDate)

For the explanation of the data fields see here.



postingDate accountingTransactionmeasureOrRatioDescriptionsignOfMeasureOrRatioamountAccountingRatiocurrencyTransactionamountAccountingRatioBalbankClientcustomerTypeproductaccountingCategoryimpairmentStageimpairmentType
13/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-247.45EUR247.450Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
13/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-247.45EUR247.450Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Capital Payout ContractualCapital amount-0EUR00Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Capital Payout ContractualCapital amount-0EUR00Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Capital Payout ContractualCapital amount-33000EUR330000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Capital Payout ContractualCapital amount-33000EUR330000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Capital Payout Real PaymentCapital amount-33000EUR330000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Capital Payout Real PaymentCapital amount-33000EUR330000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+247.45EUR247.450Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+247.45EUR247.450Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-247.5EUR247.50Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-247.5EUR247.50Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-1.76EUR1.760Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-1.76EUR1.760Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+112.93EUR112.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+112.93EUR112.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+247.5EUR247.50Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+247.5EUR247.50Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-248.33EUR248.330Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-248.33EUR248.330Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-1.76EUR1.760Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Accrual Incoming Interest in Arrears
Difference between contractual and effective interest rate excl. amortisation-1.76EUR
Accrual/deferral of interest+EUR159,75159,750Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/
12
03/
2018112.93
2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+
112.93EUR
EUR159,75159,750Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/
12
03/
2018112.93
2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+
112.93EUR
EUR266,25266,250Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/
12
03/
2018175.9
2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+
175.9EUR
EUR266,25266,250Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/
12
03/
2018175.9
2019LN A Accrual Incoming Interest in Arrears
Accrual/deferral of interest+175.9EUR
Difference between contractual and effective interest rate excl. amortisation-EUR6,336,330Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/
12
03/
2018
2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation
+
-
2.96EUR2.96
EUR6,336,330Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/
12
03/
2018
2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation
+2.96
-
2.96EUR
EUR15,3215,320Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/
12
03/
2018
2019LN A
Capital Real RepaymentCapital amount+812.8EUR812.8
Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-EUR15,3215,320Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/
12
03/
2018
2019LN A
Capital Real RepaymentCapital amount
Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+
812.8EUR812.8
EUR1438,831438,830Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/
12
03/
2018
2019LN A
Capital Real RepaymentCapital amount
Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+
820.91EUR820.91
EUR1438,831438,830Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/
12
03/
2018
2019LN A
Capital Real RepaymentCapital amount+820.91EUR820.91
Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-EUR1439,701439,700Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/
12
03/
2018
2019LN A
Capital Real RepaymentCapital amount+906.85EUR906.85
Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-EUR1439,701439,700Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31
20/
12
03/
2018
2019LN A
Capital Real RepaymentCapital amount
Accrual Incoming Interest in ArrearsAccrual/deferral of interest+
906.85EUR906.85
EUR159,75159,750Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31
20/
12
03/
2018
2019LN A
Capital Repayment ContractualCapital amount
Accrual Incoming Interest in ArrearsAccrual/deferral of interest+
812.8EUR812.8
EUR159,75159,750Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31
20/
12
03/
2018
2019LN A
Capital Repayment ContractualCapital amount
Accrual Incoming Interest in ArrearsAccrual/deferral of interest+
812.8EUR812.8
EUR249,19249,190Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31
20/
12
03/
2018
2019LN A
Capital Repayment ContractualCapital amount
Accrual Incoming Interest in ArrearsAccrual/deferral of interest+
820.91EUR820.91
EUR249,19249,190Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31
20/
12
03/
2018
2019LN A
Capital Repayment
Incoming Interest in Arrears ContractualCapital amount+
820.91EUR820.91
EUR303,36303,360Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31
20/
12
03/
2018
2019LN A
Capital Repayment Contractual
Incoming Interest in Arrears Real PaymentsCapital amount+
906.85EUR906.85
EUR303,36303,360Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31
20/
12
03/
2018
2019LN A
Capital Repayment Contractual
Incoming Interest in Arrears Real PaymentsCapital amount+
906.85EUR906.85
EUR303,36303,360Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31
20/
12
03/
2018
2019LN A
Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-229.79EUR229.79
Incoming Interest in Arrears ContractualCapital amount+EUR303,36303,360Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31
20/
12
03/
2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-229.79EUR229.79
2019LN A Incoming Interest in Arrears ContractualCapital amount+EUR322,27322,270Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31
20/
12
03/
2018
2019LN A
Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+248.33EUR248.33
Incoming Interest in Arrears Real PaymentsCapital amount+EUR322,27322,270Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31
20/
12
03/
2018
2019LN A
Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+248.33EUR248.33
Incoming Interest in Arrears Real PaymentsCapital amount+EUR322,27322,270Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31
20/
12
03/
2018
2019LN A Incoming Interest in Arrears ContractualCapital amount+
119.99EUR119.99
EUR322,27322,270Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31
20/
12
03/
2018
2019LN A
Incoming Interest in Arrears
Capital Repayment ContractualCapital amount+
119.99EUR119.99
EUR1660,001660,000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31
20/
12
03/
2018
2019LN A
Incoming Interest in Arrears Contractual
Capital Real RepaymentCapital amount+
205.93EUR205.93
EUR1660,001660,000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31
20/
12
03/
2018
2019LN A
Incoming Interest in Arrears Contractual
Capital Real RepaymentCapital amount+
205.93EUR205.93
EUR1660,001660,000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31
20/
12
03/
2018
2019LN A
Incoming Interest in Arrears Contractual
Capital Real RepaymentCapital amount+
214.04EUR214.04
EUR1660,001660,000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31
20/
12
03/
2018
2019LN A
Incoming Interest in Arrears
Capital Repayment ContractualCapital amount+
214.04EUR214.04
EUR1660,001660,000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31
20/
12
03/
2018
2019LN A
Incoming Interest in Arrears Real Payments
Capital Repayment ContractualCapital amount+
119.99EUR119.99
EUR1660,001660,000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31
20/
12
03/
2018
2019LN A
Incoming Interest in Arrears Real Payments
Capital Repayment ContractualCapital amount+
119.99EUR119.99
EUR1660,001660,000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31
20/
12
03/
2018
2019LN A
Incoming Interest in Arrears Real Payments
Capital Real RepaymentCapital amount+
205.93EUR205.93
EUR1660,001660,000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31
20/
12
03/
2018
2019LN A Accrual Incoming Interest in Arrears
Real PaymentsCapital amount
Difference between contractual and effective interest rate excl. amortisation+
205.93EUR205.93
EUR13,6213,620Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31
20/
12
03/
2018
2019LN A Accrual Incoming Interest in Arrears
Real PaymentsCapital amount
Difference between contractual and effective interest rate excl. amortisation+
214.04EUR214.04
EUR13,6213,620Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31
20/
12
03/
2018
2019LN A Accrual Incoming Interest in Arrears
Real PaymentsCapital amount+214.04EUR214.04
Difference between contractual and effective interest rate excl. amortisation-EUR15,3215,320Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02
20/
01175.9
03/2019LN A Accrual Incoming Interest in Arrears
Accrual/deferral of interest+175.9EUR
Difference between contractual and effective interest rate excl. amortisation-EUR15,3215,320Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02
20/
01
03/2019LN A
Accrual Incoming Interest in ArrearsAccrual/deferral of interest+175.9EUR175.9
Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-EUR1438,831438,830Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02
20/
01
03/2019LN A
Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+2.81EUR2.81
Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-EUR1438,831438,830Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02
20/
01
03/2019LN A
Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+2.81EUR2.81
Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+EUR1464,621464,620Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02
20/
01
03/2019LN A
Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+2.96EUR2.96
Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+EUR1464,621464,620Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
022.96
31/01/2019LN A Accrual Incoming Interest in Arrears
Difference between contractual and effective interest rate excl. amortisation+2.96EUR
Accrual/deferral of interest+EUR249,19249,190Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02
31/01/2019LN A
Capital Real RepaymentCapital amount
Accrual Incoming Interest in ArrearsAccrual/deferral of interest+
837.91EUR837.91
EUR249,19249,190Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02
31/01/2019LN A
Capital Real RepaymentCapital amount
Accrual Incoming Interest in ArrearsAccrual/deferral of interest+
837.91EUR837.91
EUR295,02295,020Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02
31/01/2019LN A
Capital Repayment ContractualCapital amount
Accrual Incoming Interest in ArrearsAccrual/deferral of interest+
837.91EUR837.91
EUR295,02295,020Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02
31/01/2019LN A
Capital Repayment Contractual
Incoming Interest in Arrears Real PaymentsCapital amount+
837.91EUR837.91
EUR349,65349,650Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02
31/01/2019LN A
Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-222.18EUR222.18
Incoming Interest in Arrears ContractualCapital amount+EUR349,65349,650Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02
31/01/2019LN A
Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-222.18EUR222.18
Incoming Interest in Arrears ContractualCapital amount+EUR349,65349,650Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02
31/01/2019LN A
Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+229.79EUR229.79
Incoming Interest in Arrears Real PaymentsCapital amount+EUR349,65349,650Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02
31/01/2019LN A
Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.
Capital Real RepaymentCapital amount+
229.79EUR229.79
EUR1660,001660,000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02
31/01/2019LN A
Incoming Interest in Arrears
Capital Repayment ContractualCapital amount+
188.93EUR188.93
EUR1660,001660,000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02
31/01/2019LN A
Incoming Interest in Arrears
Capital Repayment ContractualCapital amount+
188.93EUR188.93
EUR1660,001660,000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02
31/01/2019LN A
Incoming Interest in Arrears Real Payments
Capital Real RepaymentCapital amount+
188.93EUR188.93
EUR1660,001660,000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02
31/01/2019LN A Accrual Incoming Interest in Arrears
Real PaymentsCapital amount
Difference between contractual and effective interest rate excl. amortisation+
188.93EUR188.93
EUR7,307,300Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Accrual Incoming Interest in Arrears
Accrual/deferral of interest
Difference between contractual and effective interest rate excl. amortisation+
177.4EUR177.4
EUR7,307,300Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Accrual Incoming Interest in Arrears
Accrual/deferral of interest177.4
Difference between contractual and effective interest rate excl. amortisation+
177.4EUR2.81
EUR13,6213,620Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+
2.81EUR
EUR13,6213,620Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A
Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+2.81EUR2.81
Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-EUR1464,621464,620Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A
Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+6.55EUR6.55
Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-EUR1464,621464,620Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A
Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+6.55EUR6.55
Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+EUR1477,371477,370Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+
222.18EUR222.18
EUR1477,371477,370Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31
02/01/2019LN A
Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+222.18EUR222.18
Accrual Incoming Interest in ArrearsAccrual/deferral of interest+EUR273,17273,170Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+EUR273,17273,170Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31
02/01/2019LN A
Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-223.54EUR223.54
Accrual Incoming Interest in ArrearsAccrual/deferral of interest+EUR295,02295,020Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31
02/01/2019LN A
Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-223.54EUR223.54
Accrual Incoming Interest in ArrearsAccrual/deferral of interest+EUR295,02295,020Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20
02/
03
01/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation
-10.02
+
10.02EUR
EUR7,307,300Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20
02/
0310.02
01/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation
-
+EUR
10.02
7,307,300Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20
02/
03
01/2019LN A Accrual Incoming Interest in Arrears
Accrual/deferral of interest
Difference between contractual and effective interest rate excl. amortisation+
113.53EUR113.53
EUR7,607,600Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20
02/
03
01/2019LN A Accrual Incoming Interest in Arrears
Accrual/deferral of interest113.53
Difference between contractual and effective interest rate excl. amortisation+
113.53EUR
EUR7,607,600Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20
02/
03
01/2019LN A
Accrual Incoming Interest in ArrearsAccrual/deferral of interest+177.4EUR177.4
Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+EUR1477,211477,210Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20
02/
03
01/2019LN A
Accrual Incoming Interest in ArrearsAccrual/deferral of interest+177.4EUR177.4
Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+EUR1477,211477,210Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20
02/
03
01/2019LN A
Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+6.55EUR6.55
Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-EUR1477,371477,370Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20
02/
03
01/2019
LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+6.55EUR6.55
LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-EUR1477,371477,370Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20
31/
03
12/
2019
2018LN A
Capital Real RepaymentCapital amount
Accrual Incoming Interest in ArrearsAccrual/deferral of interest+
842.18EUR842.18
EUR273,17273,170Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20
31/
03
12/
2019
2018LN A
Capital Real RepaymentCapital amount
Accrual Incoming Interest in ArrearsAccrual/deferral of interest+
842.18EUR842.18
EUR273,17273,170Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20
31/
03
12/
2019
2018LN A Capital
Real Repayment
Payout ContractualCapital amount
+843.1
-EUR
843.1
0,000,000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20
31/
03
12/
2019
2018LN A Capital
Real Repayment
Payout ContractualCapital amount
+
-
843.1EUR843.1
EUR0,000,000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20
31/
03
12/
2019
2018LN A
Capital Repayment
Incoming Interest in Arrears ContractualCapital amount+
842.18EUR842.18
EUR330,57330,570Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20
31/
03
12/
2019
2018LN A
Capital Repayment
Incoming Interest in Arrears ContractualCapital amount+
842.18EUR842.18
EUR330,57330,570Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20
31/
03
12/
2019
2018LN A
Capital Repayment Contractual
Incoming Interest in Arrears Real PaymentsCapital amount+
843.1EUR843.1
EUR330,57330,570Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20
31/
03
12/
2019
2018LN A
Capital Repayment Contractual
Incoming Interest in Arrears Real PaymentsCapital amount+
843.1EUR843.1
EUR330,57330,570Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20
31/
03
12/
2019
2018LN A
Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-210.3EUR210.3
Incoming Interest in Arrears Real PaymentsCapital amount+EUR377,78377,780Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20
31/
03
12/
2019
2018LN A
Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-210.3EUR210.3
Incoming Interest in Arrears Real PaymentsCapital amount+EUR377,78377,780Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20
31/
03
12/
2019
2018LN A
Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+223.54EUR223.54
Incoming Interest in Arrears ContractualCapital amount+EUR377,78377,780Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20
31/
03
12/
2019
2018LN A
Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+223.54EUR223.54
Incoming Interest in Arrears ContractualCapital amount+EUR377,78377,780Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20
31/
03
12/
2019
2018LN A
Incoming Interest in Arrears
Capital Repayment ContractualCapital amount+
183.74EUR183.74
EUR1660,001660,000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20
31/
03
12/
2019
2018LN A
Incoming Interest in Arrears
Capital Repayment ContractualCapital amount+
183.74EUR183.74
EUR1660,001660,000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20
31/
03
12/
2019
2018LN A
Incoming Interest in Arrears Contractual
Capital Real RepaymentCapital amount+
184.66EUR184.66
EUR1660,001660,000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20
31/
03
12/
2019
2018LN A
Incoming Interest in Arrears Contractual
Capital Real RepaymentCapital amount+
184.66EUR184.66
EUR1660,001660,000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20
31/
03
12/
2019
2018LN A
Incoming Interest in Arrears Real Payments
Capital Repayment ContractualCapital amount+
183.74EUR183.74
EUR1660,001660,000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20
31/
03
12/
2019
2018LN
A Incoming Interest in Arrears Real Payments
A Capital Real RepaymentCapital amount+
183.74EUR183.74
EUR1660,001660,000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20
31/
03
12/
2019
2018LN A
Incoming Interest in Arrears Real Payments
Capital Real RepaymentCapital amount+
184.66EUR184.66
EUR1660,001660,000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20
31/
03
12/
2019
2018LN A
Incoming Interest in Arrears Real Payments
Capital Repayment ContractualCapital amount+
184.66EUR184.66
EUR1660,001660,000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/
03
12/
2019
2018LN A
Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation10.02
Capital Payout ContractualCapital amount-
10.02EUR
EUR200000,00200000,000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/
03
12/
2019
2018LN A
Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation10.02
Capital Payout Real PaymentCapital amount-
10.02EUR
EUR200000,00200000,000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/
03
12/
2019
2018LN A
Accrual Incoming Interest in ArrearsAccrual/deferral of interest+113.53EUR113.53
Capital Payout Real PaymentCapital amount-EUR200000,00200000,000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/
03
12/
2019
2018LN A
Accrual Incoming Interest in ArrearsAccrual/deferral of interest+113.53EUR113.53
Capital Payout ContractualCapital amount-EUR200000,00200000,000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/
03
12/
2019
2018LN A Accrual Incoming Interest in Arrears
Accrual/deferral of interest
Difference between contractual and effective interest rate excl. amortisation+
173.28EUR173.28
EUR7,607,600Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/
03
12/
2019
2018LN A Accrual Incoming Interest in Arrears
Accrual/deferral of interest173.28
Difference between contractual and effective interest rate excl. amortisation+
173.28EUR
EUR7,607,600Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/
03
12/
2019
2018LN A
Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-4.87EUR4.87
Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-EUR1477,211477,210Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage
1 (HEALTHY)31/03/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-4.87EUR4.87
1 (HEALTHY)
31/12/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-EUR1477,211477,210Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/
03
12/
2019
2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+
210.3EUR210.3
EUR1499,921499,920Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/
03
12/
2019
2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+
210.3EUR210.3
EUR1499,921499,920Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31
30/
03
09/
2019
2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-
210.79EUR210.79
EUR1499,921499,920Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31
30/
03
09/
2019
2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-
210.79EUR210.79
EUR1499,921499,920Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)